For the current review, members had been randomly assigned to receive 6 infusions of ketamine, administered 3 times each week about two consecutive months, compared to 6 infusions on the psychoactive placebo control midazolam (picked out because its pharmacokinetic parameters and nonspecific behavioral effects are comparable to those of ketamine) https://donaldt112ulz0.liberty-blog.com/profile